Onward Medical N.V. (FRA:63E)
4.315
0.00 (0.00%)
At close: Nov 28, 2025
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement.
It operates in France, Germany, the Netherlands, the United Kingdom, and Switzerland. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
| Country | Netherlands |
| Founded | 2014 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 103 |
| CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5611 Netherlands | |
| Website | onwd.com |
Stock Details
| Ticker Symbol | 63E |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David Marver | Chief Executive Officer |
| Amori Fraser | Chief Financial Officer |
| Robert Odell | Chief Operating Officer |